Glenner, G. G. & Wong, C. W. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885–890 (1984).

Article  CAS  PubMed  Google Scholar 

van Dyck, C. H. et al. Lecanemab in early Alzheimer’s disease. N. Engl. J. Med. 388, 9–21 (2023).

Article  PubMed  Google Scholar 

Mintun, M. A. et al. Donanemab in early Alzheimer’s disease. N. Engl. J. Med. 384, 1691–1704 (2021).

Article  CAS  PubMed  Google Scholar 

Serrano-Pozo, A., Aldridge, G. M. & Zhang, Q. Four decades of research in Alzheimer’s disease (1975–2014): a bibliometric and scientometric analysis. J. Alzheimers Dis. 59, 763–783 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923 (1993).

Article  CAS  PubMed  Google Scholar 

Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278, 1349–1356 (1997).

Article  CAS  PubMed  Google Scholar 

Corder, E. H. et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180–184 (1994).

Article  CAS  PubMed  Google Scholar 

Reiman, E. M. et al. Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat. Commun. 11, 667 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mattsson, N. et al. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer’s disease. Alzheimers Dement. 14, 913–924 (2018).

Article  PubMed  Google Scholar 

Belloy, M. E. et al. APOE genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol. 80, 1284–1294 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Granot-Hershkovitz, E. et al. APOE alleles’ association with cognitive function differs across Hispanic/Latino groups and genetic ancestry in the study of Latinos — investigation of neurocognitive aging (HCHS/SOL). Alzheimers Dement. 17, 466–474 (2021).

Article  CAS  PubMed  Google Scholar 

Rajabli, F. et al. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations. PLoS Genet. 14, e1007791 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Blue, E. E., Horimoto, A. R. V. R., Mukherjee, S., Wijsman, E. M. & Thornton, T. A. Local ancestry at APOE modifies Alzheimer’s disease risk in Caribbean Hispanics. Alzheimers Dement. 15, 1524–1532 (2019).

Article  PubMed  Google Scholar 

Griswold, A. J. et al. Increased APOE ε4 expression is associated with the difference in Alzheimer’s disease risk from diverse ancestral backgrounds. Alzheimers Dement. 17, 1179–1188 (2021).

Article  CAS  PubMed  Google Scholar 

Nuytemans, K. et al. Identifying differential regulatory control of APOE ɛ4 on African versus European haplotypes as potential therapeutic targets. Alzheimers Dement. 18, 1930–1942 (2022).

Article  CAS  PubMed  Google Scholar 

Fortea, J. et al. APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease. Nat. Med. 30, 1284–1291 (2024).

Article  CAS  PubMed  Google Scholar 

Qian, J. et al. APOE-related risk of mild cognitive impairment and dementia for prevention trials: an analysis of four cohorts. PLoS Med. 14, e1002254 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Stites, S. D. et al. Patients asking about APOE gene test results? Here’s what to tell them. J. Fam. Pract. 71, E1–E7 (2022).

PubMed  PubMed Central  Google Scholar 

Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat. Genet. 53, 1276–1282 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat. Genet. 54, 412–436 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huq, A. J. et al. Polygenic score modifies risk for Alzheimer’s disease in APOE ε4 homozygotes at phenotypic extremes. Alzheimers Dement. 13, e12226 (2021).

Google Scholar 

Ebenau, J. L. et al. Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score. Alzheimers Dement. 13, e12229 (2021).

Google Scholar 

Erickson, C. M. et al. KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD. Neurology 92, e1878–e1889 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Belloy, M. E. et al. Association of klotho vs heterozygosity with risk of Alzheimer disease in individuals who carry APOE4. JAMA Neurol. 77, 849–862 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Neitzel, J. et al. KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease. Nat. Commun. 12, 3825 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ali, M. et al. Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of klotho heterozygosity on disease risk. PLoS ONE 17, e0267298 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huq, A. J. et al. Genetic resilience to Alzheimer’s disease in APOE ε4 homozygotes: a systematic review. Alzheimers Dement. 15, 1612–1623 (2019).

Article  PubMed  Google Scholar 

Serrano-Pozo, A. & Growdon, J. H. Is Alzheimer’s disease risk modifiable? J. Alzheimers Dis. 67, 795–819 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Jaisa-Aad, M., Muñoz-Castro, C. & Serrano-Pozo, A. Update on modifiable risk factors for Alzheimer’s disease and related dementias. Curr. Opin. Neurol. 37, 166–181 (2024).

Article  PubMed  Google Scholar 

Kolli, A. et al. Interactions between the apolipoprotein E4 gene and modifiable risk factors for cognitive impairment: a nationally representative panel study. BMC Geriatr. 22, 938 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Langella, S. et al. Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer’s disease. Nat. Commun. 14, 5120 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Park, S.-Y. et al. Modifying effects of race and ethnicity and APOE on the association of physical activity with risk of Alzheimer’s disease and related dementias. Alzheimers Dement. 19, 507–517 (2023).

Article  CAS  PubMed